Literature DB >> 29573542

Pulmonary transit time derived from pulmonary angiography for the diagnosis of hepatopulmonary syndrome.

He Zhao1,2, Jiaywei Tsauo1, Xiaowu Zhang1, Huaiyuan Ma2, Ningna Weng2, Luhua Wang3, Xiao Li1,2.   

Abstract

BACKGROUND & AIMS: Pulmonary transit time (PTT) is the transit time of blood from the right side of the heart to the left side of the heart. The aim of the present study was to evaluate the role of the PTT derived from pulmonary angiography in the diagnosis of hepatopulmonary syndrome (HPS).
METHODS: From December 2014 to September 2015, all patients with chronic liver disease and/or portal hypertension undergoing a venous interventional radiologic procedure at our institution were eligible for inclusion in this prospective study. Pulmonary angiography was performed in all patients, and the PTT, which was defined as the time between opacification of the pulmonary trunk and the right border of the left atrium, was determined.
RESULTS: A total of 53 patients were included, 20 of whom had a positive contrast-enhanced echocardiography result and an elevated alveolar-arterial oxygen gradient were considered to have HPS. PTT was significantly shorter in patients with HPS than in those without [median, 3.34 (interquartile range, 3.01-3.67) seconds vs 4.0 (interquartile range, 3.67-4.17) seconds; P < .001]. The area under the receiver operating characteristic curve of PTT for diagnosing HPS was 0.83 (95% confidence interval, 0.70-0.92). The optimal cut-off value of PTT for diagnosing HPS, based on Youden's index, was 3.55 seconds. The sensitivity, specificity and accuracy of PTT < 3.55 seconds for diagnosing HPS were 70%, 85% and 79% respectively.
CONCLUSIONS: Pulmonary transit time derived from pulmonary angiography is useful for diagnosing HPS, especially for patients with intracardiac shunts and inadequate echocardiographic windows.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  digital subtraction angiography; hepatopulmonary syndrome; intrapulmonary vascular dilations; portal hypertension; pulmonary transit time

Mesh:

Year:  2018        PMID: 29573542     DOI: 10.1111/liv.13741

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  4 in total

Review 1.  Cardiac Imaging in Liver Transplantation Candidates: Current Knowledge and Future Perspectives.

Authors:  Yannis Dimitroglou; Constantina Aggeli; Alexandra Alexopoulou; Sophie Mavrogeni; Dimitris Tousoulis
Journal:  J Clin Med       Date:  2019-12-03       Impact factor: 4.241

Review 2.  Pulmonary manifestations of chronic liver disease: a comprehensive review.

Authors:  Stergios Soulaidopoulos; Ioannis Goulis; Evangelos Cholongitas
Journal:  Ann Gastroenterol       Date:  2020-03-27

Review 3.  Advances in Diagnostic Imaging of Hepatopulmonary Syndrome.

Authors:  Bi-Wei Luo; Zhi-Yong Du
Journal:  Front Med (Lausanne)       Date:  2022-01-10

4.  Technetium-99m-labeled macroaggregated albumin lung perfusion scan for diagnosis of hepatopulmonary syndrome: A prospective study comparing brain uptake and whole-body uptake.

Authors:  He Zhao; Jiaywei Tsauo; Xiao-Wu Zhang; Huai-Yuan Ma; Ning-Na Weng; Gong-Shun Tang; Xiao Li
Journal:  World J Gastroenterol       Date:  2020-03-14       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.